Nucleic acids are emerging as a third generation of pharmaceuticals following the clinical accomplishments of small-molecule drugs and biologics like proteins and monoclonal antibody (mAb) therapies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results